Featuring perspectives from Dr Jacqueline Broadway-Duren, Dr Bita Fakhri, Ms Corinne Hoffman and Dr Jeff Sharman, including the following topics:
- Introduction: Key Factors in the Management of Chronic Lymphocytic Leukemia (CLL) (0:00)
- Role of Covalent Bruton Tyrosine Kinase (BTK) Inhibitors for Newly Diagnosed CLL (12:02)
- Role of Time-Limited Up-Front Treatment, Including Therapy Combining BTK Inhibitors and Venetoclax, for Newly Diagnosed CLL (37:55)
- Role of Pirtobrutinib for Relapsed/Refractory (R/R) CLL (1:02:07)
- CAR (Chimeric Antigen Receptor) T-Cell Therapy for R/R CLL (1:16:48)
NCPD information and select publications
Research To Practice | Oncology Videos